NIH-fund­ed tri­als of­ten miss di­ver­si­ty tar­gets, small study shows

De­spite in­creased ur­gency to di­ver­si­fy clin­i­cal tri­als, a ma­jor­i­ty of NIH-fund­ed tri­als that had com­plet­ed en­roll­ment in a re­cent study missed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.